Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Actinogen Medical Limited ( (AU:ACW) ) has provided an announcement.
Actinogen Medical Limited has announced the application for the quotation of new securities to be listed on the Australian Securities Exchange (ASX). This move indicates an expansion in the company’s financial activities, potentially enhancing its capital and positioning within the biotechnology industry.
More about Actinogen Medical Limited
Actinogen Medical Limited operates in the biotechnology industry, focusing on the development of innovative therapeutics. The company primarily targets neurological diseases and disorders, aiming to address unmet medical needs in this sector.
YTD Price Performance: 2400.0%
Average Trading Volume: 810,100
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $52.71M
For a thorough assessment of ACW stock, go to TipRanks’ Stock Analysis page.
